|
|
Impact of the COVID-19 Pandemic on Patients with Alzheimers Disease and Alzheimers Disease Related Dementias |
| 1 U01 AG076478-01 |
|
NIA |
2021 |
|
|
Alzheimers Disease Sequencing Project Phenotype Harmonization Consortium |
| 1 U24 AG074855-01 |
|
NIA |
2021 |
|
|
Higher Order Chromatin and Genetic Risk for Alzheimer's Disease |
| 2 R01 AG050986-06A1 |
|
NIA |
2021 |
|
|
Sleep Health Profiles Predicting Impaired Cognition and Depressive Symptoms in Older Adults: Extending Novel Statistical Methods in Multi-Cohort Applications |
| 2 RF1 AG056331-04A1 |
|
NIA |
2021 |
|
|
Systematic Characterization of Tauopathy-Associated Genetic Variation using Multiplexed Reporter Assays |
| 5 F30 AG064832-03 |
|
NIA |
2021 |
|
|
Practice Effects in Cognitive Aging: Implications for Biomarkers and Early Diagnosis |
| 5 F31 AG064834-02 |
|
NIA |
2021 |
|
|
Human induced pluripotent stem cell modeling of genetic risk factors for Alzheimers disease |
| 5 F32 AG060695-03 |
|
NIA |
2021 |
|
|
Sex Hormones, Aging, Alzheimers Disease and Other Neurodegenerative Diseases in Women |
| 5 F32 AG063442-03 |
|
NIA |
2021 |
|
|
Incident Vascular Brain Injury, Probable Alzheimer's Disease, and Cognitive Change in Elderly American Indians |
| 5 K01 AG057821-04 |
|
NIA |
2021 |
|
|
Hypertensive Disorders of Pregnancy and Subsequent Risk of Vascular Dementia, Alzheimer's Disease, or Related Dementia: A Retrospective Cohort Study Taking into Account Mid-Life Mediating Factors. |
| 5 K01 AG058781-02 |
|
NIA |
2021 |
